Annual accounts receivable:
$479.10M+$39.80M(+9.06%)Summary
- As of today (May 29, 2025), NBIX annual accounts receivable is $479.10 million, with the most recent change of +$39.80 million (+9.06%) on December 31, 2024.
- During the last 3 years, NBIX annual accounts receivable has risen by +$293.60 million (+158.27%).
- NBIX annual accounts receivable is now at all-time high.
Performance
NBIX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$516.00M+$36.90M(+7.70%)Summary
- As of today (May 29, 2025), NBIX quarterly accounts receivable is $516.00 million, with the most recent change of +$36.90 million (+7.70%) on March 31, 2025.
- Over the past year, NBIX quarterly accounts receivable has increased by +$65.30 million (+14.49%).
- NBIX quarterly accounts receivable is now at all-time high.
Performance
NBIX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NBIX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.1% | +14.5% |
| 3 y3 years | +158.3% | +95.8% |
| 5 y5 years | +278.4% | +247.2% |
NBIX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.3% | at high | +95.8% |
| 5 y | 5-year | at high | +278.4% | at high | +249.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NBIX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $516.00M(+7.7%) |
| Dec 2024 | $479.10M(+9.1%) | $479.10M(-0.4%) |
| Sep 2024 | - | $481.10M(+2.8%) |
| Jun 2024 | - | $468.20M(+3.9%) |
| Mar 2024 | - | $450.70M(+2.6%) |
| Dec 2023 | $439.30M(+25.5%) | $439.30M(+5.1%) |
| Sep 2023 | - | $417.80M(+7.8%) |
| Jun 2023 | - | $387.60M(-1.0%) |
| Mar 2023 | - | $391.60M(+11.9%) |
| Dec 2022 | $350.00M(+88.7%) | $350.00M(+16.2%) |
| Sep 2022 | - | $301.20M(+8.0%) |
| Jun 2022 | - | $279.00M(+5.9%) |
| Mar 2022 | - | $263.50M(+42.0%) |
| Dec 2021 | $185.50M(+18.1%) | $185.50M(+13.2%) |
| Sep 2021 | - | $163.80M(+3.3%) |
| Jun 2021 | - | $158.50M(+7.2%) |
| Mar 2021 | - | $147.80M(-5.9%) |
| Dec 2020 | $157.10M(+24.1%) | $157.10M(+0.1%) |
| Sep 2020 | - | $156.90M(+5.7%) |
| Jun 2020 | - | $148.40M(-0.1%) |
| Mar 2020 | - | $148.60M(+17.4%) |
| Dec 2019 | $126.60M(+120.5%) | $126.60M(+9.8%) |
| Sep 2019 | - | $115.32M(+20.9%) |
| Jun 2019 | - | $95.36M(+32.5%) |
| Mar 2019 | - | $71.96M(+25.4%) |
| Dec 2018 | $57.41M(+84.4%) | $57.41M(+6.1%) |
| Sep 2018 | - | $54.10M(+26.9%) |
| Jun 2018 | - | $42.65M(-4.4%) |
| Mar 2018 | - | $44.62M(+43.4%) |
| Dec 2017 | $31.13M(>+9900.0%) | $31.13M(+4.4%) |
| Sep 2017 | - | $29.82M(+390.9%) |
| Jun 2017 | - | $6.07M(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $3.28M(-37.1%) |
| Sep 2010 | - | $5.22M(-53.7%) |
| Jun 2010 | - | $11.28M(+6820.2%) |
| Sep 2008 | - | $163.00K(+8050.0%) |
| Jun 2008 | - | $2000.00(-83.3%) |
| Mar 2008 | - | $12.00K(-55.6%) |
| Dec 2007 | $27.00K(-99.6%) | $27.00K(+50.0%) |
| Sep 2007 | - | $18.00K(-48.6%) |
| Jun 2007 | - | $35.00K(-87.2%) |
| Mar 2007 | - | $274.00K(-96.2%) |
| Dec 2006 | $7.19M(+738.1%) | $7.19M(+1568.4%) |
| Sep 2006 | - | $431.00K(+6.2%) |
| Jun 2006 | - | $406.00K(-93.2%) |
| Mar 2006 | - | $5.93M(+591.1%) |
| Dec 2005 | $858.00K(-89.6%) | $858.00K(-44.2%) |
| Sep 2005 | - | $1.54M(-93.3%) |
| Jun 2005 | - | $22.83M(+440.0%) |
| Mar 2005 | - | $4.23M(-48.5%) |
| Dec 2004 | $8.21M(-39.9%) | $8.21M(+9.6%) |
| Sep 2004 | - | $7.49M(+61.8%) |
| Jun 2004 | - | $4.63M(+1.5%) |
| Mar 2004 | - | $4.56M(-66.6%) |
| Dec 2003 | $13.66M(+5430.0%) | $13.66M(-16.7%) |
| Sep 2003 | - | $16.40M(-49.1%) |
| Jun 2003 | - | $32.22M(+8.1%) |
| Mar 2003 | - | $29.80M(>+9900.0%) |
| Dec 2002 | $247.00K(-97.5%) | $247.00K(-89.7%) |
| Sep 2002 | - | $2.39M(-12.2%) |
| Jun 2002 | - | $2.72M(-44.4%) |
| Mar 2002 | - | $4.89M(-50.8%) |
| Dec 2001 | $9.95M | $9.95M(+401.2%) |
| Jun 2001 | - | $1.99M(+59.7%) |
| Mar 2001 | - | $1.24M |
FAQ
- What is Neurocrine Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual accounts receivable year-on-year change?
- What is Neurocrine Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly accounts receivable year-on-year change?
What is Neurocrine Biosciences annual accounts receivable?
The current annual accounts receivable of NBIX is $479.10M
What is the all time high annual accounts receivable for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual accounts receivable is $479.10M
What is Neurocrine Biosciences annual accounts receivable year-on-year change?
Over the past year, NBIX annual accounts receivable has changed by +$39.80M (+9.06%)
What is Neurocrine Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of NBIX is $516.00M
What is the all time high quarterly accounts receivable for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly accounts receivable is $516.00M
What is Neurocrine Biosciences quarterly accounts receivable year-on-year change?
Over the past year, NBIX quarterly accounts receivable has changed by +$65.30M (+14.49%)